RUO‘ZENLog in
Stocks › Healthcare › RVTY

Revvity stockRVTY

Revvity Inc · NYSE
$150.83
−5.39% on the day
close Nov 5, 2026
What is happening with the stock

Revvity trades at $150.83, 12.2% below its 52-week high (Nov 3, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +56.1% year to date, +63.2% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 4, 2027.

Why it is falling · −5.4% · Nov 5, 2026

No news on Revvity today. The Healthcare sector moved −4.30% (median).

All moves of the day →
Closing price, 6 monthsdetailed chart in the terminal
92.0913317352-week high 171.74May 8, 2026Nov 5, 2026
Reported figurestrailing 12 months
🔒 Sector comparison, estimates and ratings are in the terminal

Ratings, candles, signals and the screener for RVTY — after you log in

Open the terminal
From 52-week high−12.2%
High171.74 Nov 3, 2026
vs 50-day avg+2.6%
vs 200-day avg+33.8%
Year to date+56.1%
12 months+63.2%
P/E27.3
Dividend yield0.18%
EarningsFeb 4
Market cap$16.8B
Chart patternflat base
Exchange · sinceNYSE

Frequently asked questions about Revvity

What is the Revvity stock price?

At the close on Nov 5, 2026: $150.83 (−5.39% on the day). 52-week high: $171.74 on Nov 3, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Revvity report earnings?

The next quarterly report is on Feb 4, 2027. Last quarter, earnings per share changed +17% year over year, revenue +2%.

Does Revvity pay dividends?

Yes, the dividend yield is about 0.18% a year.

Where does Revvity trade and how to buy it?

Ticker RVTY, exchange NYSE. You can buy it through a broker with access to US exchanges.

Should I buy Revvity now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for RVTY are in the terminal after you log in.

Similar stocks

More on RVTY

Included in lists